Axtria, an AI-first data analytics innovator focused on transforming life sciences, has announced its highly anticipated ...

The metabolic effects of weight management medicines extend beyond appetite regulation. Still, with more questions about ...

Gilead Sciences has joined the list of pharma groups hiking their capital investment plans in the US, adding $11 billion in ...

Shionogi has reached a JPY 151 billion ($1.04 billion) agreement to buy the pharmaceutical subsidiary of Japan Tobacco, Torii ...

According to Politico, Trump will issue an executive order in the next few days to pursue the use of a so-called 'most ...

In a surprise post this afternoon, new FDA Commissioner Dr Martin Makary announced a completed pilot at the FDA of a ...

Robert F Kennedy Jr has launched a project to trawl federal databases to try to identify why there has been an increase in ...

In Part 6 of the Life Sciences Industry Report, we’ve collated key thought leadership from 2024 that looks at ways in which ...

The UK exported £127 million in medicinal and pharmaceutical products to India in 2024, according to the organisation's ...

AstraZeneca and Daiichi Sankyo's anti-HER2 drug Enhertu has been shown to provide a benefit in a phase 3 trial in early-stage ...

According to the WSJ, the universal vaccine project is being pioneered by two recently appointed senior scientists in the NIH ...

The aim is to make sure that foreign companies "receive the same level of regulatory oversight and scrutiny as domestic ...